Although we observed an increase in Rac1 activity in BRAFi‐R melanoma cells, we did not observe a statistically significant reduction in the elevated Rac1 activity of BRAFi‐R melanoma cells after combined treatment with an IL‐6 Ab and Box5. The gene discussed is RAC1; the disease is melanoma.